Service delivery in acute ischemic stroke patients: Does sex matter?
====================================================================

* Friedrich Medlin
* Davide Strambo
* Dimitris Lambrou
* Valeria Caso
* Patrik Michel

## Abstract

**Background** Women with acute ischemic stroke (AIS) are older and have higher preexisting handicap than men. Given that these factors do not fully explain their poorer long-term outcomes, we sought to investigate potential sex differences in the delivery of acute stroke care in a large cohort of consecutive AIS patients.

**Methodss** We analyzed all patients from the Acute STroke Registry and Analysis of Lausanne (ASTRAL) from 03/2003-12/2019. Multivariate analyses were performed on acute time metrics, revascularization therapies, ancillary exams for stroke work-up, subacute symptomatic carotid artery revascularization, frequency of change in goals of care (palliative care) and length of hospital stay.

**Results** Of the 5347 analyzed patients, 45% were biologically female and the median age was 74.6 years. After multiple adjustments, female sex was significantly associated with higher onset-to-door (adjusted hazard ratio (aHR):1.09, 95% confidence interval (CI) 1.04-1.14) and door-to-endovascular-puncture intervals (aHR:1.15, 95%CI:1.05-1.25). Women underwent less diagnostic exams (adjusted odds ratio (aOR): 0.94, 95%CI:0.85-1.04), fewer subacute carotid revascularizations (aOR:0.69, 95% CI:0.33-1.18) and had longer hospital stays (aHR:1.03, 95%CI:0.99-1.07), but these differences were not statistically significant. We found no differences in the rates of acute revascularization treatments, or in the frequency of change of goals of treatments.

**Conclusions** In this retrospective analysis of a large, consecutive AIS cohort, female sex was associated with unfavorable pre- and inhospital time metrics, and lesser diagnostic exam and carotid revascularization rates. Such indicators of less effective stroke care delivery may contribute to the poorer long-term functional outcomes in female patients and require further attention.

Key Words
*   Stroke
*   Sex Differences
*   Service Delivery.

## Introduction

While there is mounting evidence that women are older and have higher preexisting handicap and comorbidities at stroke onset than men 1–3, this only partially explains the poorer long-term functional outcome in female stroke patients. Possibly, acute stroke care treatment, work-up, and secondary prevention could differ between sexes and contribute to these findings and more data are needed on this latter aspect of stroke management as well as on care delivery in the acute and subacute phases. Considering the expected age-dependent increase in stroke incidence in women in the next decades, this issue becomes even more important. In this quality assurance project, we sought to investigate potential sex differences in care delivery in acute ischemic stroke (AIS) in a large consecutive cohort of patients treated at our institution.

## Methods

### Patients and data collection

We reviewed retrospective data from March 2003 to December 2019 of all patients in the prospectively constructed Acute STroke Registry and Analysis of Lausanne (ASTRAL).4 ASTRAL collects data from all AIS patients admitted to the stroke unit and/or intensive care unit of Lausanne University Hospital (CHUV) within 24 hours of last known well time. Our center’s patient population consists of one-third distant referrals from community hospitals and stroke units mainly addressed for acute revascularization treatment, and about two-thirds of patients from the primary catchment area.

We recorded demographic data, vascular risk factors (arterial hypertension, smoking, atrial fibrillation, valve replacements, dyslipidemia, coronary artery disease and diabetes mellitus), multiple other comorbidities (like a history of renal disease, cancer, dementia, and depression) and previous cerebrovascular events. We collected medications at the time of stroke and the pre-stroke modified Rankin score (mRS). The National Institutes of Health Stroke Score (NIHSS) was performed or supervised on arrival by NIHSS-certified personnel.

Neuroimaging was CT-based up to 4/2018, after which MRI became the initial imaging modality of choice. CT-or MR-arteriography and perfusion imaging for supratentorial strokes were performed whenever possible.

Stroke mechanism was classified according to TOAST 5. The rest of the acute stroke management and secondary prevention followed European Stroke Organisation guidelines in use at the time of stroke. Rankin-certified personnel assessed mRS at 7 days, and then at 3 months in the outpatient clinic (or by a structured telephone interview for patients unable to attend the 3-month outpatient clinic).

### Outcomes

We chose eight outcomes to assess potential differences in care delivery between female and male stroke patients:

*   - Onset-to-door (OTD) time analyzed as a continuous variable, i.e., the time between the reported symptom onset (or last proof of good health in unknown and sleep-onset patients) and arrival at our tertiary hospital

*   - Proportion of acute revascularization treatments (intravenous thrombolysis (IVT) and/or endovascular treatment (EVT) in the first 24 hours. The decision to perform acute revascularization treatment followed the written multidisciplinary hospital guidelines that mirror Swiss 6 and European recommendations. 7

*   - Times to acute revascularization treatment, analyzed as continuous variables:
    
    *   ∘ Door-to-needle time in IVT, and/or
    
    *   ∘ Door-to-puncture (DTP) time in EVT

*   - Diagnostic exam score: we attributed one point for each of the following eight ancillary diagnostic exams performed during the subacute hospital phase in our stroke center: neurovascular ultrasound (cervical arteries with transcranial Doppler whenever a bone window was present), subacute cranial CT, subacute cranial MRI, subacute cerebral CTA or MRA (with or without cervical arteries), transthoracic and/or transesophageal echocardiography (TTE, TEE), and patent foramen ovale (PFO) detection by TTE and/or TEE with microbubble injection. The decision to perform these exams was taken by the treating physician in the stroke unit.

*   - Carotid revascularization treatments (CEA and/or CAS) within one month for a symptomatic stenosis ≥ 50%. The decision to perform these treatments was based on our published multidisciplinary hospital guidelines that are subject to Swiss 8 and European 9 recommendations at the time of the intervention. In summary, the preferred intervention was CEA; CAS was offered to patients with anatomical situations unsuitable for CEA, restenosis after previous revascularizations, post-radiation stenosis, and on demand from patients aged below 70 years.

*   - Change in goals of care (CGC) towards a palliative care attitude during the hospitalization for the index stroke. Patients or their legal representatives and the neurologist in charge addressed a CGC based on clinical variables such as initial course, comorbid conditions, pre- stroke disability, prior patient directives, or presumed wishes of the patient. Any CGC decision was registered in the patient’s medical record and in ASTRAL, including the time from stroke onset.

*   - Length of hospital stay, analyzed as a continuous variable. The onset of the hospital stay was defined as the time of arrival at the hospital of patients admitted thereafter to the stroke unit and/or intensive care unit of our institution (for in-hospital stroke, it was defined as the last proof of good health). The end of the hospital stay coincided with either discharge from the stroke unit and/or intensive care unit to another institution, or to another in-house acute medical service.

We applied the STROBE method (Strengthening the Reporting of Observational Studies in Epidemiology).10

## Ethical considerations

ASTRAL is registered in our institution as a clinical and research databank and follows the institutional regulations on clinical and research registries. Patients received a written document from the hospital that their routinely collected clinical data may be used for quality and scientific purposes, and we did not consider a patient’s decision to opt out from data analysis as this was a quality assurance project of the treatment practice in our institution. This type of analysis that aims to evaluate treatment efficiency and safety for quality purposes falls outside of the Swiss Human Research Act of 2011.

## Data availability

The raw, anonymized data that support the findings of this study are available from the corresponding author upon reasonable request and after signing a data transfer and use agreement (DTUA). If such data are then used for a publication, the publication methods should be communicated, and internationally recognized authorship rules should be applied.

## Statistical Analyses

Study participants’ data were analyzed according to sex classification, as shown in figure 1. We assessed demographic, clinical, and radiological variables from the acute phase of stroke (<24 hours) recorded in the ASTRAL database. Continuous variables were summarized as median with interquartile range (IQR) and categorical variables as percentages and numbers.

Initially, univariate comparisons were performed according to sex and the unadjusted odds ratios (ORs) were evaluated. Subsequently, multiple regression analyses of the aforementioned eight main outcomes were conducted to identify independent associations with sex, after adjusting for the following 23 covariates: age, ethnicity (Caucasian vs. all others), prehospital referral pattern (patients coming from primary vs. secondary hospital catchment areas), time of symptom onset to hospital admission, history of prior cerebrovascular events, stroke severity, pre-hospital admission mRS, cerebrovascular risk factors (hypertension, diabetes, hyperlipidemia, smoking, atrial fibrillation, alcohol abuse, body-mass index), peripheral artery disease, coronary artery disease, cardiac heart valves, cardiac ejection fraction, migraine, active cancer, depression and psychosis. Additional adjustments were made for specific analyses: OTD time to assess the proportion of acute revascularization treatment (IVT and/or EVT), OTD time and carotid stenosis grade to evaluate carotid revascularization treatments, and OTD time to assess length of hospital stay and a CGC.

For *continuous* response variables, a Cox proportional hazards model was employed to associate covariates with the response. This approach has the advantage that no distributional assumptions are made for the continuous response. For *categorical* outcomes, with limited values, a proportional odds model was used to identify important links between response and background information.

Missing data were imputed using multivariate imputation by chained equations (MICE) methodology. Five imputed datasets were generated. Stepwise selection methods were employed to identify significant associations of the selected covariates with the specific outcome on each imputed dataset. Results of the five imputed analyses were combined appropriately to formulate the final analysis results that were given as adjusted odds ratios (aORs) with confidence intervals (CIs) for categorical and ordinal outcomes, and adjusted hazard ratios (aHR) with CIs for continous outcomes. All statistical analyses were conducted using the R statistical software version 4.4.2 (R Core Team 2017).

## Results

Retrospective data from 5347 patients who fulfilled the inclusion criteria were analyzed (figure 1). Of these patients, 45% were female, 3.8% were of non-Caucasian ethnicity and the median age was 74.6 years. The proportion of women in the population referred from the secondary catchment area was 30.4%, lower than the proportion of men (34.7%). Detailed sex-specific description of the cohort is described in table 1 and supplemental table 1; it resembles closely our previous sex-specific analysis concentrating on clinical presentations and long-term outcomes 2.

View this table:
[Table 1:](http://medrxiv.org/content/early/2023/06/27/2023.06.19.23291634/T1)

Table 1: 
Overall and sex-specific unadjusted baseline characteristics of the population. Values are expressed as medians and interquartile range for continuous variables, and absolute counts and percentages for categorical variables unless otherwise stated.

Unadjusted comparisons (see table 1 and supplemental table 1) showed a significantly higher OTD time (3.4 vs. 3.0 hours; HR 1.02; CI95% 1.01-1.03), a lower proportion of IVT (22.7% vs. 24.6%; OR 0.9; CI95% 0.79-1.02) and a slightly higher proportion of EVT treatments (15.2% vs. 15.1%; OR 0.98; CI95% 0.84-1.14) for women compared to men. Furthermore, women had fewer diagnostic exams (median number 3 vs. 3, OR 0.9 CI95% 0.87-0.93), fewer subacute carotid revascularization treatments (1.7% vs. 4.4%; OR 0.36 CI95% 0.25 - 0.52), longer lengths of hospital stay (9 vs. 8 days; HR 1.01 CI95% 1.00 - 1.01) and a higher proportion of change in goals of care (12.3% vs. 9.1%; OR 1.40 CI95% 1.18 - 1.67) compared to men.

In the adjusted multivariate analysis (see table 2) female sex remained significantly associated with higher OTD (aHR: 1.09, 95%CI 1.04-1.14; p<0.01) and DTP times (aHR: 1.15, 95%CI 1.05-1.25; p<0.01). While not statistically significant, we observed a lower number of diagnostic exams (aOR: 0.94, 95%CI 0.85-1.04; p=0.21), fewer subacute carotid revascularization treatments (aOR: 0.69 95%CI 0.33-1.18; p=0.147) and longer hospital durations (aHR: 1.03, 95%CI 0.99-1.07; p=0.19) in women. Further, in the multivariate analysis we no longer saw trends in the proportions of IVT and/or EVT or changes in goals of treatments between male and female sex patients.

View this table:
[Table 2:](http://medrxiv.org/content/early/2023/06/27/2023.06.19.23291634/T2)

Table 2: 
Summary of the multivariate analysis results for each of the eight sex-specific outcomes (reference male sex)

## Discussion

In this retrospective study of 5347 consecutive AIS patients admitted to a comprehensive stroke center, we found that female sex was significantly associated with longer OTD and DTP times. Additionally, we noted numerically fewer diagnostic exams in women during the acute hospital stay, fewer subacute carotid revascularization treatments and longer hospital durations, but these differences did not reach statistical significance. Altogether, these indicators of less effective stroke care delivery may contribute to the poorer long-term functional outcomes in female patients 2, 11 and warrants further attention.

Existing literature focusing on sex differences in acute stroke care and service delivery is limited and yields inconsistent results. An older analysis from the GWTG-Stroke program 12 and a recent large retrospective study in China 1 did not show significant sex differences in acute management and intrahospital and discharge performance measures. A pooled analysis of five randomized controlled trials found that women were more likely to be admitted to an acute stroke unit 14, whereas other studies from France and Canada showed the contrary.14, 15

This same pooled analysis showed that women were less likely to benefit from intensive care treatment and acute interventions such as intubation 13, nasogastric feeding 13, and treatment for fever 13. The latter finding was confirmed by a recent nationwide study from Canada demonstrating that women and older patients (≥80 years) had lower odds of receiving life-sustaining care, but disparities in intensive care unit admission narrowed over time.16

Regarding prehospital timing, several other studies reported longer onset-to-hospital times for women 17–22. whereas others did not find a sex-related difference. 23, 24 One plausible reason for increased pre-hospital times is that women are more often widowed and living alone, 25 leading to a later activation of emergency medical services. 21 Another explanation might be more non-focal, atypical, and non-traditional symptoms in acute stroke presentations in women, leading to under-recognition of stroke and non-activation of stroke alert pathways. 26, 27

Regarding intravenous thrombolysis, our results confirmed those of other studies showing comparable treatment rates and time metrics for both sexes. 1, 22, 23, 28, 31 However, one study of Danish public registries 21 and a recent meta-analysis of 17 studies showed 13% lower unadjusted odds of receiving IV rtPA in women. 30 Reassuringly, such differences seem to decrease towards more sex equity over time: a recent nationwide analysis in the US showed that in the last decade, utilization of rtPA increased at a faster pace in women compared to men. 31 This trend was confirmed by epidemiological data from France 15 and by the aforementioned meta-analysis by Strong and co-workers. 30 Recent data from Catalonia for the period from 2016 to 2019 showed even a higher proportion of acute reperfusion therapies in women.24

Regarding the rate of EVT, we found no differences between sexes after adjusting for several factors, whereas other studies showed higher EVT rates in women.14, 30, 32 Given that several of these other studies 14, 32 adjusted their comparisons with multiple co-variates, there is no simple explanation for these findings such as higher admission NIHSS scores or rates of atrial fibrillation.2

We found longer door-to-groin times in women treated with endovascular therapies, despite adjusting for prehospital delays. This contrasts with other studies that found similar intrahospital times for EVT. 14, 24, 33, 34 Our finding does not have an obvious explanation, but a possible explanation is a cognitive sex bias.

Regarding the in-hospital stroke work-up in the subacute phase, our results showed that we performed numerically fewer diagnostic exams in women, but this did not reach statistical significance. Again, prior literature is divided when reporting on sex differences in diagnostic evaluation of stroke, with evidence for less extracranial magnetic resonance angiography (MRA),23 echocardiography and carotid evaluation in women 35, 36 while, on the contrary, older populations 37 and multicentric studies in the US and Canada did not demonstrate significant sex inequities for these exams. 38, 39

A further main result of our study was that after adjusting for age and stenosis grade, we observed numerically fewer subacute carotid vascularization procedures in women, not reaching statistical significance. This result may be explained by evolving sex-specific treatment recommendations for symptomatic carotid stenosis. 40, 41 Some studies show a higher stroke risk in male carotid stenosis patients compared to women, probably due to higher plaque instability 42, but endarterectomy risk seems similar 43, and the meta-analysis of randomized trial data does not show a differential effect of carotid revascularization depending on biological sex. 41

As for the lengths of hospital stay, the longer hospital duration for women was not significant after adjusting for the known higher stroke severity and pre-stroke handicap.2 Longer hospitalization in women has been reported by Somerford et al 44, possibly related to the more frequent absence of a spouse at home who could participate in the care.

Finally, regarding the complex question of sex disparities in CGC in AIS, we did not observe a significant difference in CGC decisions in our adjusted analysis. This confirms what we found in our recent analysis that identified several powerful predictors of GCS, but not sex.45

Limitations of our work are its retrospective, non-randomized design in a tertiary stroke center with approximately one-third of patients being referred from other hospitals or stroke units. As a quality assurance project in a single institution, it may not be applicable to other populations, in particular, non-Caucasian and younger populations. As stated above, we did not measure several variables that may have confounded our main outcomes, such as educational level, extent of social networks, isolation and loneliness, and socioeconomic and sociocultural status.

The strengths of our work are the consecutive nature of the collected data over a long period with pre-specified and standardized data collection, and rigorous adjustment of multiple confounders for the eight main outcome analyses.

In conclusion, this study suggests that female patients with AIS arriving at a comprehensive stroke center have longer OTD and DTP times while other indicators for care delivery are not statistically different. Some of these observations may contribute to the explanation of poorer long-term functional outcomes in female patients and require further attention.

## Data Availability

The raw, anonymized data that support the findings of this study are available from the corresponding author upon reasonable request and after signing a data transfer and use agreement (DTUA). If such data are then used for a publication, the publication methods should be communicated, and internationally recognized authorship rules should be applied.

## Disclosures

F. Medlin: his institution received research grants from the Swiss Heart Foundation.

D. Strambo: none.

D. Lambrou: none.

V. Caso: received speaker fees from Bayer and Boehringer-Ingelheim within the past 3 years

P. Michel: research grants from the Swiss Heart Foundation, Swiss National Science Foundation and the Faculty of Biology and Medicine of the University of Lausanne.

## Author contributions

Friedrich Medlin: Study concept and design, data analysis and interpretation, drafting of the manuscript.

Dimitris Lambrou: Statistical analysis, software support, drafting of the manuscript. Davide Strambo: Data collection, data analysis and interpretation.

Valeria Caso: Study concept and design, critical revision of the manuscript.

Patrik Michel: Study concept and design, data collection, collection and handling of funding, critical revision of the manuscript, supervision of study.

## Supplemental material

![Supplemental figure 1.](http://medrxiv.org/https://www.medrxiv.org/content/medrxiv/early/2023/06/27/2023.06.19.23291634/F1.medium.gif)

[Supplemental figure 1.](http://medrxiv.org/content/early/2023/06/27/2023.06.19.23291634/F1)

Supplemental figure 1. 
Study flow diagram

View this table:
[Supplemental table 1:](http://medrxiv.org/content/early/2023/06/27/2023.06.19.23291634/T3)

Supplemental table 1: 
Additional overall and sex-specific unadjusted baseline characteristics of the population. Values are expressed as medians and interquartile range for continuous variables, and absolute counts and percentages for categorical variables unless otherwise stated.

View this table:
[Supplemental table 2:](http://medrxiv.org/content/early/2023/06/27/2023.06.19.23291634/T4)

Supplemental table 2: 
Overall and sex-specific unadjusted number of diagnostic exams in the subacute phase of the hospitalization. Values are expressed as absolute counts and percentages for categorical variables unless otherwise stated.

View this table:
[Supplemental table 3:](http://medrxiv.org/content/early/2023/06/27/2023.06.19.23291634/T5)

Supplemental table 3: 
Significant variables in the MVA of OTD time

View this table:
[Supplemental table 4:](http://medrxiv.org/content/early/2023/06/27/2023.06.19.23291634/T6)

Supplemental table 4: 
Significant variables in the MVA of diagnostic exam score

View this table:
[Supplemental table 5:](http://medrxiv.org/content/early/2023/06/27/2023.06.19.23291634/T7)

Supplemental table 5: 
Significant variables in the MVA of acute revascularization treatment (IVT/EVT)

View this table:
[Supplemental table 6:](http://medrxiv.org/content/early/2023/06/27/2023.06.19.23291634/T8)

Supplemental table 6: 
Significant variables in the MVA of door-to-needle-time

View this table:
[Supplemental table 7:](http://medrxiv.org/content/early/2023/06/27/2023.06.19.23291634/T9)

Supplemental table 7: 
Significant variables in the MVA of door-to-groin-time

View this table:
[Supplemental table 8:](http://medrxiv.org/content/early/2023/06/27/2023.06.19.23291634/T10)

Supplemental table 8: 
Significant variables in the MVA of subacute revascularization at 6 months for symptomatic carotid stenosis (50-99%)

View this table:
[Supplemental table 9:](http://medrxiv.org/content/early/2023/06/27/2023.06.19.23291634/T11)

Supplemental table 9: 
Significant variables in the MVA of length of hospital stay

View this table:
[Supplemental table 10:](http://medrxiv.org/content/early/2023/06/27/2023.06.19.23291634/T12)

Supplemental table 10: 
Significant variables in the MVA of change in goals of care decision

## Acknowledgements

We thank Mrs. Price Hirt, PhD, for critical review and English-language correction of the manuscript.

## Non-standard Abbreviations and Acronyms

AIS
:   Acute ischemic Stroke
CGC
:   Change in goals of care
CTA
:   Computed tomography angiography
DTP
:   Door-to-puncture
EVT
:   Endovascular treatment
IVT
:   Intravenous thrombolysis
NIHSS
:   National Institutes of Health Stroke Score
MRA
:   Magnetic Resonance Angiography
mRS
:   Modified Rankin score
OTD
:   Onset-to-door
PFO
:   Patent foramen ovale
TEE
:   Transesophageal echocardiography
TTE
:   Transthoracic echocardiography

*   Received June 19, 2023.
*   Revision received June 19, 2023.
*   Accepted June 27, 2023.


*   © 2023, Posted by Cold Spring Harbor Laboratory

The copyright holder for this pre-print is the author. All rights reserved. The material may not be redistributed, re-used or adapted without the author's permission.

## References

1.  1.Gu HQ, Wang CJ, Yang X, Liu C, Wang X, Zhao XQ, Wang YL, Liu LP, Meng X, Jiang Y, Li H, Wang YJ, Li ZX. Sex differences in vascular risk factors, in-hospital management and outcomes of patients with acute ischemic stroke in China. Eur J Neurol. 2022 Jan;29(1):188–198.
    
    

2.  2.Medlin F, Amiguet A, Eskandari A, Michel P. Sex differences in consecutive acute ischemic strokes:causes, clinical presentation and outcomes. Eur J Neurol. 2020 Aug;27(8):1680–1688.
    
    

3.  3.Hoyer C, Schlenker J, Sandikci V, Ebert A, Wittayer M, Platten M, Szabo K. Sex-Specifi Differences in Pre-Stroke Characteristics Reveal Vulnerability of Elderly Women. J. Pers. Med. 2022,12, 344.
    
    

4.  4.Michel P, Odier C, Rutgers M, Reichhart M, Maeder P, Meuli R, Wintermark M, Maghraoui A, Faouzi M, Croquelois A, Ntaios G. The Acute STroke Registry and Analysis of Lausanne (ASTRAL): design and baseline analysis of an ischemic stroke registry including acute multimodal imaging. Stroke. 2010;41:2491–2498.
    
    [Abstract/FREE Full Text](http://medrxiv.org/lookup/ijlink/YTozOntzOjQ6InBhdGgiO3M6MTQ6Ii9sb29rdXAvaWpsaW5rIjtzOjU6InF1ZXJ5IjthOjQ6e3M6ODoibGlua1R5cGUiO3M6NDoiQUJTVCI7czoxMToiam91cm5hbENvZGUiO3M6OToic3Ryb2tlYWhhIjtzOjU6InJlc2lkIjtzOjEwOiI0MS8xMS8yNDkxIjtzOjQ6ImF0b20iO3M6NTA6Ii9tZWRyeGl2L2Vhcmx5LzIwMjMvMDYvMjcvMjAyMy4wNi4xOS4yMzI5MTYzNC5hdG9tIjt9czo4OiJmcmFnbWVudCI7czowOiIiO30=) 

5.  5. Adams HP Jr, Bendixen BH, Kappelle LJ, Biller J, Love BB, Gordon DL, Marsh EE. 3rd Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of ORG 10172 in Acute Stroke Treatment. Stroke.1993;24:35–41.
    
    [CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.1161/01.str.24.1.35&link_type=DOI) 
    
    [PubMed](http://medrxiv.org/lookup/external-ref?access_num=7678184&link_type=MED&atom=%2Fmedrxiv%2Fearly%2F2023%2F06%2F27%2F2023.06.19.23291634.atom) 

6.  6.Michel P, Diepers M, Mordasini P, Schubert T, Bervini D, Rouvé JD, Gasche Y, Schwegler G, Bonvin C, Nedeltchev K, Carrera E, Kägi G, Cereda C, Nyffeler T, Wetzel S et al. On behalf of the Swiss Stroke Society. Acute Revascularization in Ischemic Stroke: Updated Swiss Guidelines. Clinical and Translational Neuroscience. 2021; 5(1):9.
    
    

7.  7.Fiehler J, Cognard C, Gallitelli M, Jansen O, Kobayashi A, Mattle HP, Muir KW, Mazighi M, Schaller K, Schellinger PD. European recommendations on organisation of interventional care in acute stroke (EROICAS). Eur Stroke J. 2016 Sep;1(3):155–170.
    
    [PubMed](http://medrxiv.org/lookup/external-ref?access_num=http://www.n&link_type=MED&atom=%2Fmedrxiv%2Fearly%2F2023%2F06%2F27%2F2023.06.19.23291634.atom) 

8.  8.Déglise S, Dubuis C, Mosimann P, Saucy F, Engelberger S, Hirt L, Michel P, Corpataux JM. Prise en charge des sténoses carotidiennes [Management of the carotid artery stenosis]. Rev Med Suisse. 2013 Jun 19;9(391):1305–11
    
    

9.  9.Naylor AR, Ricco JB, de Borst GJ, Debus S, de Haro J, Halliday A, Hamilton G, Kakisis J, Kakkos S, Lepidi S, Markus HS, McCabe DJ, Roy J, Sillesen H, van den Berg JC, et al. Management of Atherosclerotic Carotid and Vertebral Artery Disease: 2017 Clinical Practice Guidelines of the European Society for Vascular Surgery (ESVS). Eur J Vasc Endovasc Surg. 2018 Jan;55(1):3–81.
    
    [CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.1016/j.ejvs.2017.06.021&link_type=DOI) 
    
    [PubMed](http://medrxiv.org/lookup/external-ref?access_num=28851594&link_type=MED&atom=%2Fmedrxiv%2Fearly%2F2023%2F06%2F27%2F2023.06.19.23291634.atom) 

10. 10.Von Elm E, Altman DG, Egger M, Pocock SJ, Gotzsche PC, Vandenbroucke JP; STROBE Initiative. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Epidemiology 2007; 18:800–804.
    
    [CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.1097/EDE.0b013e3181577654&link_type=DOI) 
    
    [PubMed](http://medrxiv.org/lookup/external-ref?access_num=18049194&link_type=MED&atom=%2Fmedrxiv%2Fearly%2F2023%2F06%2F27%2F2023.06.19.23291634.atom) 
    
    [Web of Science](http://medrxiv.org/lookup/external-ref?access_num=000262285900027&link_type=ISI) 

11. 11.Xu M, Amarilla Vallejo A, Cantalapiedra Calvete C, Rudd A, Wolfe C, O’Connell MDL, Douiri A. Stroke Outcomes in Women: A Population-Based Cohort Study. Stroke. 2022 Oct;53(10):3072–3081.
    
    

12. 12.Reeves MJ, Fonarow GC, Zhao X, Smith EE, Schwamm LH; Get With The Guidelines-Stroke Steering Committee & Investigators. Quality of care in women with ischemic stroke in the GWTG program. Stroke. 2009 Apr;40(4):1127–33
    
    [Abstract/FREE Full Text](http://medrxiv.org/lookup/ijlink/YTozOntzOjQ6InBhdGgiO3M6MTQ6Ii9sb29rdXAvaWpsaW5rIjtzOjU6InF1ZXJ5IjthOjQ6e3M6ODoibGlua1R5cGUiO3M6NDoiQUJTVCI7czoxMToiam91cm5hbENvZGUiO3M6OToic3Ryb2tlYWhhIjtzOjU6InJlc2lkIjtzOjk6IjQwLzQvMTEyNyI7czo0OiJhdG9tIjtzOjUwOiIvbWVkcnhpdi9lYXJseS8yMDIzLzA2LzI3LzIwMjMuMDYuMTkuMjMyOTE2MzQuYXRvbSI7fXM6ODoiZnJhZ21lbnQiO3M6MDoiIjt9) 

13. 13.Carcel C, Wang X, Sandset EC, Delcourt C, Arima H, Lindley R, Hackett ML, Lavados P, Robinson TG, Muñoz Venturelli P, Olavarría VV, Brunser A, Berge E, Chalmers J, Woodward M et al. Sex differences in treatment and outcome after stroke: Pooled analysis including 19,000 participants. Neurology. 2019 Dec 10;93(24).
    
    

14. 14.Yu AYX, Austin PC, Rashid M, Fang J, Porter J, Vyas MV, Smith EE, Joundi RA, Edwards JD, Reeves MJ, Kapral MK. Sex Differences in Intensity of Care and Outcomes After Acute Ischemic Stroke Across the Age Continuum. Neurology. 2023 Jan 10;100(2).
    
    

15. 15.Olié V, Grave C, Tuppin P, Duloquin G, Béjot Y, Gabet A. Patients Hospitalized for Ischemic Stroke and Intracerebral Hemorrhage in France: Time Trends (2008-2019), In-Hospital Outcomes, Age and Sex Differences. J Clin Med. 2022 Mar 17;11(6):1669.
    
    

16. 16.Joundi RA, Smith EE, Yu AYX, Rashid M, Fang J, Kapral MK. Age-Specific and Sex-Specific Trends in Life-Sustaining Care After Acute Stroke. J Am Heart Assoc. 2021 Sep 21;10(18):e021499.
    
    

17. 17.Menon SC, Pandey DK, Morgenstern LB. Critical factors determining access to acute stroke care. Neurology 1998; 51: 427–32.
    
    [CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.1212/WNL.51.2.427&link_type=DOI) 
    
    [PubMed](http://medrxiv.org/lookup/external-ref?access_num=9710014&link_type=MED&atom=%2Fmedrxiv%2Fearly%2F2023%2F06%2F27%2F2023.06.19.23291634.atom) 

18. 18.Barr J, McKinley S, O’Brien E, Herkes G. Patient recognition of and response to symptoms of TIA or stroke. Neuroepidemiology 2006; 26: 168–75.
    
    [CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.1159/000091659&link_type=DOI) 
    
    [PubMed](http://medrxiv.org/lookup/external-ref?access_num=16493205&link_type=MED&atom=%2Fmedrxiv%2Fearly%2F2023%2F06%2F27%2F2023.06.19.23291634.atom) 
    
    [Web of Science](http://medrxiv.org/lookup/external-ref?access_num=000236736100008&link_type=ISI) 

19. 19.Mandelzweig L, Goldbourt U, Boyko V, Tanne D. Preceptual, social, and behavioral factors associated with delays in seeking medical care in patients with symptoms of acute care. Stroke 2006; 37: 1248–53.
    
    [Abstract/FREE Full Text](http://medrxiv.org/lookup/ijlink/YTozOntzOjQ6InBhdGgiO3M6MTQ6Ii9sb29rdXAvaWpsaW5rIjtzOjU6InF1ZXJ5IjthOjQ6e3M6ODoibGlua1R5cGUiO3M6NDoiQUJTVCI7czoxMToiam91cm5hbENvZGUiO3M6OToic3Ryb2tlYWhhIjtzOjU6InJlc2lkIjtzOjk6IjM3LzUvMTI0OCI7czo0OiJhdG9tIjtzOjUwOiIvbWVkcnhpdi9lYXJseS8yMDIzLzA2LzI3LzIwMjMuMDYuMTkuMjMyOTE2MzQuYXRvbSI7fXM6ODoiZnJhZ21lbnQiO3M6MDoiIjt9) 

20. 20.Foerch C, Misselwitz B, Humpich M, Steinmetz H, Neumann-Haefelin T, Sitzer M. Sex disparity in the access of elderly patients to acute stroke care. Stroke 2007; 38: 2123–26.
    
    [Abstract/FREE Full Text](http://medrxiv.org/lookup/ijlink/YTozOntzOjQ6InBhdGgiO3M6MTQ6Ii9sb29rdXAvaWpsaW5rIjtzOjU6InF1ZXJ5IjthOjQ6e3M6ODoibGlua1R5cGUiO3M6NDoiQUJTVCI7czoxMToiam91cm5hbENvZGUiO3M6OToic3Ryb2tlYWhhIjtzOjU6InJlc2lkIjtzOjk6IjM4LzcvMjEyMyI7czo0OiJhdG9tIjtzOjUwOiIvbWVkcnhpdi9lYXJseS8yMDIzLzA2LzI3LzIwMjMuMDYuMTkuMjMyOTE2MzQuYXRvbSI7fXM6ODoiZnJhZ21lbnQiO3M6MDoiIjt9) 

21. 21.Mainz J, Andersen G, Valentin JB, Gude MF, Johnsen SP. Disentangling Sex Differences in Use of Reperfusion Therapy in Patients With Acute Ischemic Stroke. Stroke. 2020 Aug;51(8):2332–2338
    
    

22. 22.de Ridder I, Dirks M, Niessen L, Dippel D; PRACTISE Investigators. Unequal access to treatment with intravenous alteplase for women with acute ischemic stroke. Stroke. 2013 Sep;44(9):2610–2
    
    [Abstract/FREE Full Text](http://medrxiv.org/lookup/ijlink/YTozOntzOjQ6InBhdGgiO3M6MTQ6Ii9sb29rdXAvaWpsaW5rIjtzOjU6InF1ZXJ5IjthOjQ6e3M6ODoibGlua1R5cGUiO3M6NDoiQUJTVCI7czoxMToiam91cm5hbENvZGUiO3M6OToic3Ryb2tlYWhhIjtzOjU6InJlc2lkIjtzOjk6IjQ0LzkvMjYxMCI7czo0OiJhdG9tIjtzOjUwOiIvbWVkcnhpdi9lYXJseS8yMDIzLzA2LzI3LzIwMjMuMDYuMTkuMjMyOTE2MzQuYXRvbSI7fXM6ODoiZnJhZ21lbnQiO3M6MDoiIjt9) 

23. 23.Gattringer T, Ferrari J, Knoflach M, Seyfang L, Horner S, Niederkorn K, Culea V, Beitzke M, Lang W, Enzinger C, Fazekas F. Sex-Related Differences of Acute Stroke Unit Care. Results from the Austrian Stroke Unit Registry. Stroke. 2014;45:1632–1638.
    
    [Abstract/FREE Full Text](http://medrxiv.org/lookup/ijlink/YTozOntzOjQ6InBhdGgiO3M6MTQ6Ii9sb29rdXAvaWpsaW5rIjtzOjU6InF1ZXJ5IjthOjQ6e3M6ODoibGlua1R5cGUiO3M6NDoiQUJTVCI7czoxMToiam91cm5hbENvZGUiO3M6OToic3Ryb2tlYWhhIjtzOjU6InJlc2lkIjtzOjk6IjQ1LzYvMTYzMiI7czo0OiJhdG9tIjtzOjUwOiIvbWVkcnhpdi9lYXJseS8yMDIzLzA2LzI3LzIwMjMuMDYuMTkuMjMyOTE2MzQuYXRvbSI7fXM6ODoiZnJhZ21lbnQiO3M6MDoiIjt9) 

24. 24.Silva Y, Sánchez-Cirera L, Terceño M, Dorado L, Valls A, Martínez M, Abilleira S, Rubiera M, Quesada H, Llull L, Rodríguez-Campello A, Martí-Fàbregas J, Seró L, Purroy F, Payo I et al. Sex and gender differences in acute stroke care: metrics, access to treatment and outcome. A territorial analysis of the Stroke Code System of Catalonia. Eur Stroke J. 2023 Jun;8(2):557–565.
    
    

25. 25.Reeves MJ, Prager M, Fang J, Stamplecoski M, Kapral MK. Impact of living alone on the care and outcomes of patients with acute stroke. Stroke. 2014;45:3083–3085
    
    [Abstract/FREE Full Text](http://medrxiv.org/lookup/ijlink/YTozOntzOjQ6InBhdGgiO3M6MTQ6Ii9sb29rdXAvaWpsaW5rIjtzOjU6InF1ZXJ5IjthOjQ6e3M6ODoibGlua1R5cGUiO3M6NDoiQUJTVCI7czoxMToiam91cm5hbENvZGUiO3M6OToic3Ryb2tlYWhhIjtzOjU6InJlc2lkIjtzOjEwOiI0NS8xMC8zMDgzIjtzOjQ6ImF0b20iO3M6NTA6Ii9tZWRyeGl2L2Vhcmx5LzIwMjMvMDYvMjcvMjAyMy4wNi4xOS4yMzI5MTYzNC5hdG9tIjt9czo4OiJmcmFnbWVudCI7czowOiIiO30=) 

26. 26.Bushnell C, Howard VJ, Lisabeth L, Caso V, Gall S, Kleindorfer D, Chaturvedi S, Madsen TE, Demel SL, Lee SJ, Reeves M. Sex differences in the evaluation and treatment of acute ischaemic stroke. Lancet Neurol. 2018 Jul;17(7):641–650.
    
    [CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.1016/S1474-4422(18)30201-1&link_type=DOI) 
    
    [PubMed](http://medrxiv.org/lookup/external-ref?access_num=http://www.n&link_type=MED&atom=%2Fmedrxiv%2Fearly%2F2023%2F06%2F27%2F2023.06.19.23291634.atom) 

27. 27.Ali M, van Os HJA, van der Weerd N, Schoones JW, Heymans MW, Kruyt ND, Visser MC, Wermer MJH. Sex Differences in Presentation of Stroke: A Systematic Review and Meta-Analysis. Stroke. 2022 Feb;53(2):345–354.
    
    

28. 28.Weber R, Krogias C, Eyding J, Bartig D, Meves SH, Katsanos AH, Caso V, Hacke W. Age and Sex Differences in Ischemic Stroke Treatment in a Nationwide Analysis of 1.11 Million Hospitalized Cases. Stroke. 2019 Dec;50(12):3494–3502.
    
    [PubMed](http://medrxiv.org/lookup/external-ref?access_num=http://www.n&link_type=MED&atom=%2Fmedrxiv%2Fearly%2F2023%2F06%2F27%2F2023.06.19.23291634.atom) 

29. 29.Nagaraja N, Olasoji EB, Patel UK. Sex and racial disparity in utilization and outcomes of t-PA and thrombectomy in acute ischemic stroke. J Stroke Cerebrovasc Dis. 2020 Sep;29(9):104954.
    
    [CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.1016/j.jstrokecerebrovasdis.2020.104954&link_type=DOI) 
    
    [PubMed](http://medrxiv.org/lookup/external-ref?access_num=32807414&link_type=MED&atom=%2Fmedrxiv%2Fearly%2F2023%2F06%2F27%2F2023.06.19.23291634.atom) 

30. 30.Strong B, Lisabeth LD, Reeves M. Sex differences in IV thrombolysis treatment for acute ischemic stroke: A systematic review and meta-analysis. Neurology. 2020 Jul 7;95(1).
    
    

31. 31.Otite FO, Saini V, Sur NB, Patel S, Sharma R, Akano EO, Anikpezie N, Albright K, Schmidt E, Hoffman H, Gould G, Khandelwal P, Latorre JG, Malik AM, Sacco RL, et al. Ten-Year Trend in Age, Sex, and Racial Disparity in tPA (Alteplase) and Thrombectomy Use Following Stroke in the United States. Stroke. 2021 Aug;52(8):2562–2570.
    
    [CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.1161/strokeaha.120.032132&link_type=DOI) 

32. 32.Bonkhoff AK, Karch A, Weber R, Wellmann J, Berger K. Female Stroke: Sex Differences in Acute Treatment and Early Outcomes of Acute Ischemic Stroke. Stroke. 2021 Jan;52(2):406–415
    
    

33. 33.Momen AI, Francis T, Schaafsma JD, Rac V, Baig A, Pereira VM, and Pikula A. Sex Differences in Functional Outcomes Following Endovascular Treatment for Acute Ischemic Stroke. The Canadian Journal of Neurological Sciences [https://doi.org/10.1017/cjn.2022.22](https://doi.org/10.1017/cjn.2022.22)
    
    

34. 34.Bala F, Casetta I, Nannoni S, Herlihy D, Goyal M, Fainardi E, Michel P, Thornton J, Power S, Saia V, Hegarty A, Pracucci G, Demchuk A, Mangiafico S, Boyle K et al. Sex-Related Differences in Outcomes After Endovascular Treatment of Patients With Late-Window Stroke. Stroke. 2022 Feb;53(2):311–318.
    
    

35. 35.Smith MA, Lisabeth LD, Brown DL, Morgenstern LB. Gender comparisons of diagnostic evaluation for ischemic stroke patients. Neurology. 2005 Sep 27;65(6):855–8.
    
    [CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.1212/01.wnl.0000176054.72325.0f&link_type=DOI) 
    
    [PubMed](http://medrxiv.org/lookup/external-ref?access_num=16186523&link_type=MED&atom=%2Fmedrxiv%2Fearly%2F2023%2F06%2F27%2F2023.06.19.23291634.atom) 

36. 36.Turaj W, Slowik A, Wnuk M, Szczudlik A. Gender-related differences in diagnostic evaluation and outcome of ischemic stroke in Poland. Stroke. 2009 Mar;40(3):980–2.
    
    [Abstract/FREE Full Text](http://medrxiv.org/lookup/ijlink/YTozOntzOjQ6InBhdGgiO3M6MTQ6Ii9sb29rdXAvaWpsaW5rIjtzOjU6InF1ZXJ5IjthOjQ6e3M6ODoibGlua1R5cGUiO3M6NDoiQUJTVCI7czoxMToiam91cm5hbENvZGUiO3M6OToic3Ryb2tlYWhhIjtzOjU6InJlc2lkIjtzOjg6IjQwLzMvOTgwIjtzOjQ6ImF0b20iO3M6NTA6Ii9tZWRyeGl2L2Vhcmx5LzIwMjMvMDYvMjcvMjAyMy4wNi4xOS4yMzI5MTYzNC5hdG9tIjt9czo4OiJmcmFnbWVudCI7czowOiIiO30=) 

37. 37.Gall SL, Donnan G, Dewey HM, Macdonell R, Sturm J, Gilligan A, Srikanth V, Thrift AG. Sex differences in presentation, severity, and management of stroke in a population-based study. Neurology 2010; 74: 975–81.
    
    [CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.1212/WNL.0b013e3181d5a48f&link_type=DOI) 
    
    [PubMed](http://medrxiv.org/lookup/external-ref?access_num=20181922&link_type=MED&atom=%2Fmedrxiv%2Fearly%2F2023%2F06%2F27%2F2023.06.19.23291634.atom) 

38. 38.Watanabe E, Allen NB, Dostal J, Sama D, Claus EB, Goldstein LB, Lichtman JH. Diagnostic evaluation for patients with ischemic stroke: are there sex differences? Cerebrovasc Dis 2009; 27: 450–55.
    
    [CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.1159/000209240&link_type=DOI) 
    
    [PubMed](http://medrxiv.org/lookup/external-ref?access_num=19295208&link_type=MED&atom=%2Fmedrxiv%2Fearly%2F2023%2F06%2F27%2F2023.06.19.23291634.atom) 

39. 39.Kapral MK, Ben-Yakov M, Fang J, Gladstone DJ, Saposnik G, Robertson A, Silver FL. Gender differences in carotid imaging and revascularization following stroke. Neurology 2009; 73: 1969–74.
    
    [CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.1212/WNL.0b013e3181c55eae&link_type=DOI) 
    
    [PubMed](http://medrxiv.org/lookup/external-ref?access_num=19996073&link_type=MED&atom=%2Fmedrxiv%2Fearly%2F2023%2F06%2F27%2F2023.06.19.23291634.atom) 

40. 40.The European Stroke Organisation (ESO) Executive Committee and the ESO Writing Committee: Guidelines for Management of Ischaemic Stroke and Transient Ischaemic Attack 2008. Cerebrovasc Dis 2008;25:457–507.
    
    [CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.1159/000131083&link_type=DOI) 
    
    [PubMed](http://medrxiv.org/lookup/external-ref?access_num=18477843&link_type=MED&atom=%2Fmedrxiv%2Fearly%2F2023%2F06%2F27%2F2023.06.19.23291634.atom) 
    
    [Web of Science](http://medrxiv.org/lookup/external-ref?access_num=000256571200012&link_type=ISI) 

41. 41.Bonati LH, Kakkos S, Berkefeld J, de Borst GJ, Bulbulia R, Halliday A, van Herzeele I, Koncar I, McCabe DJ, Lal A, et al. European Stroke Organisation guideline on endarterectomy and stenting for carotid artery stenosis. Eur Stroke J. 2021 Jun;6(2):I–XLVII.
    
    [CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.1177/23969873211012121&link_type=DOI) 
    
    [PubMed](http://medrxiv.org/lookup/external-ref?access_num=http://www.n&link_type=MED&atom=%2Fmedrxiv%2Fearly%2F2023%2F06%2F27%2F2023.06.19.23291634.atom) 

42. 42.van Dam-Nolen DHK, van Egmond NCM, Dilba K, Nies K, van der Kolk AG, Liem MI, Kooi ME, Hendrikse J, Nederkoorn PJ, Koudstaal PJ, van der Lugt A, Bos D. Sex Differences in Plaque Composition and Morphology Among Symptomatic Patients With Mild-to-Moderate Carotid Artery Stenosis. Stroke. 2022 Feb;53(2):370–378.
    
    

43. 43.Dansey KD, Pothof AB, Zettervall SL, Swerdlow NJ, Liang P, Schneider JR, Nolan BW, Schermerhorn ML. Clinical impact of sex on carotid revascularization. J Vasc Surg. 2020;71:1587–1594.
    
    

44. 44.Somerford PJ, Lee AH, Yau KK. Ischemic stroke hospital stay and discharge destination. Ann Epidemiol. 2004 Nov;14(10):773–7.
    
    [CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.1016/j.annepidem.2004.02.003&link_type=DOI) 
    
    [PubMed](http://medrxiv.org/lookup/external-ref?access_num=15519899&link_type=MED&atom=%2Fmedrxiv%2Fearly%2F2023%2F06%2F27%2F2023.06.19.23291634.atom) 

45. 45.Hausammann R, Maslias E, Amiguet M, Jox RJ, Borasio GD, Michel P. Goals of care changes after acute ischaemic stroke: decision frequency and predictors. BMJ Support Palliat Care. 2022 Nov 15.